Nonan-2-yl acetate
CAS No. 14936-66-4
Nonan-2-yl acetate( —— )
Catalog No. M37419 CAS No. 14936-66-4
Nonan-2-yl acetate (Aceticacid2-nonylester) is a volatile oil extracted from the aerial parts of Ruta chalepensis L. and a pheromone extracted from honey bees with potential insecticidal activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 29 | In Stock |
|
| 50MG | 37 | In Stock |
|
| 100MG | 53 | In Stock |
|
| 200MG | 77 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNonan-2-yl acetate
-
NoteResearch use only, not for human use.
-
Brief DescriptionNonan-2-yl acetate (Aceticacid2-nonylester) is a volatile oil extracted from the aerial parts of Ruta chalepensis L. and a pheromone extracted from honey bees with potential insecticidal activity.
-
DescriptionNonan-2-yl acetate (Aceticacid2-nonylester) is a volatile oil extracted from the aerial parts of Ruta chalepensis L. and a pheromone extracted from honey bees with potential insecticidal activity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number14936-66-4
-
Formula Weight186.29
-
Molecular FormulaC11H22O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCCCCCCC(C)OC(C)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
DYKDDDDK
DYKDDDDK
-
(R)-Omeprazole Sodiu...
(R)-Omeprazole (sodium) (Standard) is the analytical standard of (R)-Omeprazole (sodium). This product is intended for research and analytical applications. (R)-Omeprazole sodium is a gastric acid resistant compound with activity to inhibit gastric acid secretion. (R)-Omeprazole sodium is metabolized in vivo, and its metabolism is primarily affected by cytochrome P450 enzymes. The interaction between (R)-Omeprazole sodium and mannitol may affect its bioavailability in formulations. (R)-Omeprazole sodium exhibits reversible direct and metabolism-dependent inhibition of CYP2C19.
-
Suc-SDPF-pNA
Suc-SDPF-pNA
Cart
sales@molnova.com